ArticleMolecular therapy. Oncology2026

Class I HDAC inhibition enhances the stem-like memory properties of CRISPR-engineered CAR T cells in neuroblastoma.

Dan Cappabianca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.